Calling the anticipated March 27 launch of the HISA’s Anti-Droping and Medication Control Program “a momentous occasion,” HISA CEO Lisa Lazarus emphasized the program’s importance in a video conference with reporters March 23. Source
This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.
